[1]
Szkultecka-Debek, M. et al. 2015. An adverse events potential costs analysis based on Drug Programs in Poland. Dermatology focus. Current Issues in Pharmacy and Medical Sciences. 27, 3 (Mar. 2015), 183–186. DOI:https://doi.org/10.1515/cipms-2015-0012.